News

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...
Here’s how COVID-19 vaccine guidance is changing in the U.S. For people at high risk of severe COVID-19. The process of ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...
Peter A. McCullough, a former cardiologist who promoted unproven treatments like ivermectin and hydroxychloroquine at the ...
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...
The FDA’s new framework for COVID-19 vaccines breaks from established procedure for how the government establishes vaccine ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events ...